305 related articles for article (PubMed ID: 29352113)
21. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
[TBL] [Abstract][Full Text] [Related]
22. Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells.
Grinshtein N; Datti A; Fujitani M; Uehling D; Prakesch M; Isaac M; Irwin MS; Wrana JL; Al-Awar R; Kaplan DR
Cancer Res; 2011 Feb; 71(4):1385-95. PubMed ID: 21303981
[TBL] [Abstract][Full Text] [Related]
23. Smoothened-independent activation of hedgehog signaling by rearranged during transfection promotes neuroblastoma cell proliferation and tumor growth.
Ruan H; Luo H; Wang J; Ji X; Zhang Z; Wu J; Zhang X; Wu X
Biochim Biophys Acta; 2016 Sep; 1860(9):1961-72. PubMed ID: 27316313
[TBL] [Abstract][Full Text] [Related]
24. PLK4 inhibitor plus bortezomib exhibits a synergistic effect on treating multiple myeloma via inactivating PI3K/AKT signaling.
Xu B; Li J; Xu D; Ran Q
Ir J Med Sci; 2023 Apr; 192(2):561-567. PubMed ID: 35508865
[TBL] [Abstract][Full Text] [Related]
25. The mechanism of epithelial-mesenchymal transition induced by TGF-β1 in neuroblastoma cells.
Shao JB; Gao ZM; Huang WY; Lu ZB
Int J Oncol; 2017 May; 50(5):1623-1633. PubMed ID: 28393230
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of Polo-like kinase 4 (PLK4) induces G1 arrest via activation of the p38/p53/p21 signaling pathway in bladder cancer.
Yang Z; Sun H; Ma W; Wu K; Peng G; Ou T; Wu S
FEBS Open Bio; 2021 Sep; 11(9):2631-2646. PubMed ID: 34342940
[TBL] [Abstract][Full Text] [Related]
27. Phosphatidylinositol 3-kinase, class 2 beta (PI3KC2β) isoform contributes to neuroblastoma tumorigenesis.
Russo A; Okur MN; Bosland M; O'Bryan JP
Cancer Lett; 2015 Apr; 359(2):262-8. PubMed ID: 25622909
[TBL] [Abstract][Full Text] [Related]
28. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
[TBL] [Abstract][Full Text] [Related]
29. cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.
Chen L; Fu H; Luo Y; Chen L; Cheng R; Zhang N; Guo H
Cell Death Dis; 2017 Apr; 8(4):e2728. PubMed ID: 28383549
[TBL] [Abstract][Full Text] [Related]
30. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
31. Autophagy Inhibition Contributes to Apoptosis of PLK4 Downregulation-induced Dormant Cells in Colorectal Cancer.
Tian X; He Y; Qi L; Liu D; Zhou D; Liu Y; Gong W; Han Z; Xia Y; Li H; Wang J; Zhu K; Chen L; Guo H; Zhao Q
Int J Biol Sci; 2023; 19(9):2817-2834. PubMed ID: 37324947
[TBL] [Abstract][Full Text] [Related]
32. Polo-like kinase 4 correlates with greater tumor size, lymph node metastasis and confers poor survival in non-small cell lung cancer.
Zhou Q; Fan G; Dong Y
J Clin Lab Anal; 2020 Apr; 34(4):e23152. PubMed ID: 31876063
[TBL] [Abstract][Full Text] [Related]
33. B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma.
Ho WL; Che MI; Chou CH; Chang HH; Jeng YM; Hsu WM; Lin KH; Huang MC
Cancer Sci; 2013 Dec; 104(12):1600-8. PubMed ID: 24118321
[TBL] [Abstract][Full Text] [Related]
34. Kinome multigenic panel identified novel druggable EPHB4-V871I somatic variant in high-risk neuroblastoma.
Andolfo I; Lasorsa VA; Manna F; Rosato BE; Formicola D; Iolascon A; Capasso M
J Cell Mol Med; 2020 Jun; 24(11):6459-6471. PubMed ID: 32336043
[TBL] [Abstract][Full Text] [Related]
35. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
Zins K; Kovatchki D; Lucas T; Abraham D
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
[TBL] [Abstract][Full Text] [Related]
36. Plk4 Promotes Cancer Invasion and Metastasis through Arp2/3 Complex Regulation of the Actin Cytoskeleton.
Kazazian K; Go C; Wu H; Brashavitskaya O; Xu R; Dennis JW; Gingras AC; Swallow CJ
Cancer Res; 2017 Jan; 77(2):434-447. PubMed ID: 27872092
[TBL] [Abstract][Full Text] [Related]
37. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
[TBL] [Abstract][Full Text] [Related]
38. Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.
Wang Y; Wang L; Guan S; Cao W; Wang H; Chen Z; Zhao Y; Yu Y; Zhang H; Pang JC; Huang SL; Akiyama Y; Yang Y; Sun W; Xu X; Shi Y; Zhang H; Kim ES; Muscal JA; Lu F; Yang J
Sci Rep; 2016 Jan; 6():19423. PubMed ID: 26786851
[TBL] [Abstract][Full Text] [Related]
39. β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma.
Chang HH; Chen CH; Chou CH; Liao YF; Huang MJ; Chen YH; Wang WJ; Huang J; Hung JS; Ho WL; Jeng YM; Che MI; Lee H; Lu MY; Yang YL; Jou ST; Lin DT; Lin KH; Hsu WM; Huang MC
Clin Cancer Res; 2013 Apr; 19(7):1705-16. PubMed ID: 23444218
[TBL] [Abstract][Full Text] [Related]
40. PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma.
Yco LP; Geerts D; Koster J; Bachmann AS
Int J Oncol; 2013 Apr; 42(4):1408-16. PubMed ID: 23440329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]